Pembrolizumab and Pelareorep in Treating Patients With Advanced Pancreatic Cancer

Clinical trial NCT03723915 · TERMINATED

Trial details

NCT number: NCT03723915
Sponsor: Northwestern University
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma Stage III Pancreatic Cancer AJCC v8 Stage IV Pancreatic Cancer AJCC v8

Start date: 2018-11-14
Primary completion: 2019-12-19
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.